Neoplasia/BPH

	G protein-coupled receptors in prostate cancer: research progress and therapeutic targets. Front Cell Dev Biol Xiong W, Zhou B, Shi J, Ni D, Xiong Z. PMID: 41347146 [PubMed]
	Prognostic factors for overall survival in patients with metastatic castration-resistant prostate cancer treated with radium-223: a meta-analysis of real-world evidence. Front Oncol Song B, Shao H, He Y, Zhu X, Qin P. PMID: 41347095 [PubMed]
	Diagnostic accuracy of PSA derivatives for prostate cancer in patients with low prostate-specific antigen levels. Front Oncol Kadeer A, Maolake A, Aimaier A, Abuduwaili M, Ni Z, Li J. PMID: 41347082 [PubMed]
	Diagnostic Pitfall of Lytic Bone Lesions: A Case of Chromophobe Renal Cell Carcinoma Coexisting With Multiple Myeloma. Cureus Almutairi AM, Abusedera O, Shaheen AM Sr. PMID: 41346886 [PubMed]
	Racial Disparities in the Prescribing of Guideline-Recommended Medications for Metastatic Prostate Cancer: A Retrospective Cohort Study. Prostate Cancer Stein JN, Deal AM, Winslow H, Morgan K, Muthukrishnan H, Whang YE, Charlot M. PMID: 41346717 [PubMed]
	Development of a prognostic model based on immunogenic cell death/ferroptosis-related genes and the study of TREX1 effects on prostate cancer cells. Front Immunol Wen Y, Zhan S, Chen J, Yang J, Chen D, Zheng S, Zhu S. PMID: 41346575 [PubMed - indexed for MEDLINE]
	Silodosin in treating men With BPH-associated lower urinary tract Symptoms: A systematic review and network meta-analysis. Int J Surg Li J, Ai C, Yuan C, Wang K, Yu L, Jian Z, Luo Q, Ma X. PMID: 41346266 [PubMed - as supplied by publisher]
	Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer. Clin Transl Sci Norton N, Larson NB, Jenkins GD, Beumer JH, Langevin B, Gobbaru J, Morris MJ, Nakamura Y, Kroetz DL, Zhu HJ, O'Donnell PH, Lewis LD, Hertz DL. PMID: 41346252 [PubMed - indexed for MEDLINE]
	Effectiveness and Safety of Radium-223 for Bone-Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study. Cancer Sci Shiota M, Tatarano S, Kamba T, Kamoto T, Igawa T, Masumori N, Uemura H, Mitsunari K, Sumiyoshi T, Uemura H, Higashijima K, Tokunaga S, Eto M. PMID: 41346006 [PubMed - as supplied by publisher]
	Updated dose-response meta-analysis of sexual activity and prostate cancer risk. BMC Cancer Raeisvandi A, Omidi S, Javaheri M, Moradi H, Poorolajal J. PMID: 41345847 [PubMed - as supplied by publisher]
	Comparative effectiveness of robotic and laparoscopic radical prostatectomy: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials featuring geographic subgroup analyses. J Robot Surg Mirza W, Orakzai FK, Khan ME, Iqbal H, Khan A, Moeen-Ud-Din MB, Khan MA, Khan HM. PMID: 41345763 [PubMed - indexed for MEDLINE]
	From visualization to education: the role of 3D-Printed and virtual kidney models in training for renal cancer surgery, a systematic review. J Robot Surg Rubat Baleuri F, Pattou M, Jaffredo M, Lacroix G, Courtine C, Sarrazin J, Tamer M, Larribere H, Ricard S, Jambon E, Sabatier J, Bos F, Faessel M, Mondain-Monval O, Leng J, Bernhard JC, Margue G. PMID: 41345321 [PubMed - indexed for MEDLINE]
	Multiparametric prostate MRI improves the diagnosis of a clinically significant prostate cancer in PSA screening; but what is the benefit of additional risk calculators? Prostate Cancer Prostatic Dis Yaxley JW. PMID: 41345259 [PubMed - as supplied by publisher]
	PSMA PET in renal cell carcinoma: an update and future aspects. Semin Nucl Med Rizzo A, Treglia G. PMID: 41345015 [PubMed - as supplied by publisher]
	Reply to Constance Huck, Paul Sargos, and Alberto Bossi's Letter to the Editor re: Markus Graefen, Fabian Falkenbach, Tobias Maurer, et al. Best Systemic Therapy With or Without Radical Prostatectomy in the Management of Men With Oligometastatic Prostate Cancer: The RAMPP Randomised Controlled Trial. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.09.4144. Eur Urol Oncol Falkenbach F, Graefen M, Beyer B. PMID: 41344948 [PubMed - as supplied by publisher]
	Renal Insufficiency After Colectomy for Colon Cancer. Am Surg Plummer RJ, Elsawwah JK, Park DY, Flanagan JS, Stopper PB, Rolandelli RH, Nemeth ZH. PMID: 41343764 [PubMed - as supplied by publisher]
	Challenges of data quality for the management of prostate cancer in Tanzania: A hurdle towards improving the quality of service. PLOS Glob Public Health Nyongole O, Munishi C, Kimu N, Sangeda RZ, Mseti M, Lugina E, Kiwara F, Sirili N, Chacha F, Nicholaus B, Frumence G, Simba D, Urassa D, Sunguya B. PMID: 41343577 [PubMed]
	Identification and validation of palmitoylation-related signature genes based on machine learning for prostate cancer. PLoS One Wo Q, Shou J, Shi J, Shi L, Yang Y, Wang Y, Xie L. PMID: 41343534 [PubMed - indexed for MEDLINE]
	Improving Prostate MRI: Lessons Learned from the American College of Radiology's Prostate MR Image Quality Improvement Collaborative. Radiographics Purysko AS, Garcia-Tomkins K, Zacharias-Andrews K, Bittencourt LK, Giganti F, Turkbey B, Costa D, Gupta RT, Bhargavan-Chatfield M, Larson DB, Prostate MR Image Quality Improvement Collaborative, Prostate MR Image Quality Improvement Collaborative members. PMID: 41343296 [PubMed - indexed for MEDLINE]
	Framework for Race-Specific Prostate Cancer Detection Using Machine Learning Through Gene Expression Data: Feature Selection Optimization Approach. JMIR Bioinform Biotechnol Agustriawan D, Mulia A, Overbeek MV, Kurniawan V, Syechlo J, Widjaja M, Ahmad MI. PMID: 41342168 [PubMed]

Articles 1 - 20 / 183658

Page 1 of 9183



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy